nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—Lisinopril—dilated cardiomyopathy	0.744	1	CrCtD
Lisdexamfetamine—Aspartame—Lisinopril—dilated cardiomyopathy	0.229	1	CrCrCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0008	0.0309	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000707	0.0273	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000679	0.0262	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000581	0.0224	CcSEcCtD
Lisdexamfetamine—Lisinopril—ACE—dilated cardiomyopathy	0.000508	0.265	CrCbGaD
Lisdexamfetamine—Irritability—Furosemide—dilated cardiomyopathy	0.000461	0.0178	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000437	0.0169	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000435	0.0168	CcSEcCtD
Lisdexamfetamine—Labetalol—ADRB1—dilated cardiomyopathy	0.000399	0.208	CrCbGaD
Lisdexamfetamine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000391	0.0151	CcSEcCtD
Lisdexamfetamine—Somnolence—Spironolactone—dilated cardiomyopathy	0.000388	0.015	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000377	0.0146	CcSEcCtD
Lisdexamfetamine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00037	0.0143	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000369	0.0143	CcSEcCtD
Lisdexamfetamine—Diplopia—Lisinopril—dilated cardiomyopathy	0.000363	0.014	CcSEcCtD
Lisdexamfetamine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00036	0.0139	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000352	0.0136	CcSEcCtD
Lisdexamfetamine—Amphetamine—SLC22A5—dilated cardiomyopathy	0.00035	0.182	CrCbGaD
Lisdexamfetamine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000347	0.0134	CcSEcCtD
Lisdexamfetamine—Irritability—Lisinopril—dilated cardiomyopathy	0.000346	0.0134	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000345	0.0133	CcSEcCtD
Lisdexamfetamine—Labetalol—ADRB2—dilated cardiomyopathy	0.000336	0.175	CrCbGaD
Lisdexamfetamine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000327	0.0126	CcSEcCtD
Lisdexamfetamine—Methamphetamine—SLC22A5—dilated cardiomyopathy	0.000324	0.169	CrCbGaD
Lisdexamfetamine—Visual impairment—Furosemide—dilated cardiomyopathy	0.000322	0.0124	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000322	0.0124	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000316	0.0122	CcSEcCtD
Lisdexamfetamine—Eye disorder—Furosemide—dilated cardiomyopathy	0.000312	0.0121	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000302	0.0117	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000299	0.0115	CcSEcCtD
Lisdexamfetamine—Malnutrition—Furosemide—dilated cardiomyopathy	0.000291	0.0112	CcSEcCtD
Lisdexamfetamine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000289	0.0111	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000289	0.0111	CcSEcCtD
Lisdexamfetamine—Weight increased—Lisinopril—dilated cardiomyopathy	0.000285	0.011	CcSEcCtD
Lisdexamfetamine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000284	0.0109	CcSEcCtD
Lisdexamfetamine—Depression—Lisinopril—dilated cardiomyopathy	0.000279	0.0108	CcSEcCtD
Lisdexamfetamine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000278	0.0107	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000277	0.0107	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000276	0.0106	CcSEcCtD
Lisdexamfetamine—Rash—Spironolactone—dilated cardiomyopathy	0.000275	0.0106	CcSEcCtD
Lisdexamfetamine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000275	0.0106	CcSEcCtD
Lisdexamfetamine—Vision blurred—Furosemide—dilated cardiomyopathy	0.000274	0.0106	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000274	0.0106	CcSEcCtD
Lisdexamfetamine—Headache—Spironolactone—dilated cardiomyopathy	0.000274	0.0106	CcSEcCtD
Lisdexamfetamine—Agitation—Furosemide—dilated cardiomyopathy	0.000268	0.0103	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000264	0.0102	CcSEcCtD
Lisdexamfetamine—Nausea—Spironolactone—dilated cardiomyopathy	0.000259	0.01	CcSEcCtD
Lisdexamfetamine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000251	0.00969	CcSEcCtD
Lisdexamfetamine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00025	0.00964	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000246	0.0095	CcSEcCtD
Lisdexamfetamine—Dry mouth—Furosemide—dilated cardiomyopathy	0.000242	0.00936	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000238	0.00917	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000237	0.00916	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000233	0.00899	CcSEcCtD
Lisdexamfetamine—Skin disorder—Furosemide—dilated cardiomyopathy	0.000231	0.00891	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00023	0.00887	CcSEcCtD
Lisdexamfetamine—Anorexia—Furosemide—dilated cardiomyopathy	0.000226	0.00874	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000226	0.00873	CcSEcCtD
Lisdexamfetamine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00022	0.00849	CcSEcCtD
Lisdexamfetamine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000218	0.00843	CcSEcCtD
Lisdexamfetamine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000212	0.00819	CcSEcCtD
Lisdexamfetamine—Somnolence—Furosemide—dilated cardiomyopathy	0.000211	0.00815	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000207	0.00797	CcSEcCtD
Lisdexamfetamine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000206	0.00795	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000205	0.00792	CcSEcCtD
Lisdexamfetamine—Fatigue—Furosemide—dilated cardiomyopathy	0.000205	0.00791	CcSEcCtD
Lisdexamfetamine—Tremor—Lisinopril—dilated cardiomyopathy	0.000205	0.0079	CcSEcCtD
Lisdexamfetamine—Constipation—Furosemide—dilated cardiomyopathy	0.000203	0.00784	CcSEcCtD
Lisdexamfetamine—Angioedema—Lisinopril—dilated cardiomyopathy	0.0002	0.0077	CcSEcCtD
Lisdexamfetamine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000193	0.00745	CcSEcCtD
Lisdexamfetamine—Urticaria—Furosemide—dilated cardiomyopathy	0.000189	0.00729	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000188	0.00725	CcSEcCtD
Lisdexamfetamine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000185	0.00715	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000185	0.00713	CcSEcCtD
Lisdexamfetamine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000182	0.00702	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000178	0.00688	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000175	0.00676	CcSEcCtD
Lisdexamfetamine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000174	0.00672	CcSEcCtD
Lisdexamfetamine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000173	0.00668	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000172	0.00665	CcSEcCtD
Lisdexamfetamine—Asthenia—Furosemide—dilated cardiomyopathy	0.00017	0.00658	CcSEcCtD
Lisdexamfetamine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00017	0.00656	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000163	0.00628	CcSEcCtD
Lisdexamfetamine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000161	0.00622	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000159	0.00614	CcSEcCtD
Lisdexamfetamine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000158	0.00612	CcSEcCtD
Lisdexamfetamine—Dizziness—Furosemide—dilated cardiomyopathy	0.000157	0.00606	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000157	0.00606	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000155	0.00598	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000154	0.00594	CcSEcCtD
Lisdexamfetamine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000154	0.00593	CcSEcCtD
Lisdexamfetamine—Constipation—Lisinopril—dilated cardiomyopathy	0.000152	0.00588	CcSEcCtD
Lisdexamfetamine—Vomiting—Furosemide—dilated cardiomyopathy	0.000151	0.00583	CcSEcCtD
Lisdexamfetamine—Rash—Furosemide—dilated cardiomyopathy	0.00015	0.00578	CcSEcCtD
Lisdexamfetamine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00015	0.00578	CcSEcCtD
Lisdexamfetamine—Headache—Furosemide—dilated cardiomyopathy	0.000149	0.00575	CcSEcCtD
Lisdexamfetamine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000142	0.00547	CcSEcCtD
Lisdexamfetamine—Nausea—Furosemide—dilated cardiomyopathy	0.000141	0.00545	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000141	0.00544	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000131	0.00507	CcSEcCtD
Lisdexamfetamine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000128	0.00494	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000122	0.00471	CcSEcCtD
Lisdexamfetamine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000118	0.00455	CcSEcCtD
Lisdexamfetamine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000113	0.00438	CcSEcCtD
Lisdexamfetamine—Rash—Lisinopril—dilated cardiomyopathy	0.000112	0.00434	CcSEcCtD
Lisdexamfetamine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000112	0.00433	CcSEcCtD
Lisdexamfetamine—Headache—Lisinopril—dilated cardiomyopathy	0.000112	0.00431	CcSEcCtD
Lisdexamfetamine—Nausea—Lisinopril—dilated cardiomyopathy	0.000106	0.00409	CcSEcCtD
